In this context, we found that both CD14+ and CD14+HLA-DR+ PBMCs from PC patients with signs of lung fibrosis expressed higher levels of AIM2 and confirmed the release of IL-1α and TGF-β after its triggering. The gene discussed is TGFB1; the disease is pulmonary fibrosis.